HDAC4 (Phospho Ser632) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-HDAC4 (Phospho Ser632) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | HDAC4 (Phospho Ser632) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.03 mL, 0.1 mL, 0.2 mL |
| Concentration | 1 mg/ml |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Phospho-HDAC4 (S632) Polyclonal Antibody detects endogenous levels of HDAC4 protein only when phosphorylated at S632. Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. Histone deacetylase 4 encoded by HDAC4 belongs to class II of the histone deacetylase/acuc/apha family. It possesses histone deacetylase activity and represses transcription when tethered to a promoter. Histone deacetylase 4 does not bind DNA directly, but through transcription factors MEF2C and MEF2D. It seems to interact in a multiprotein complex with RbAp48 and HDAC3. |
| Immunogen | Immunogen: Synthesized peptide derived from human HDAC4 around the phosphorylation site of S632 |
| Other Names | [Rabbit HDAC4 (phospho Ser632); HDAC4; KIAA0288; Histone deacetylase 4; HD4] |
| Gene, Accession # | [HDAC4], Gene ID: 9759, NCBI: NP_006028.2, UniProt: P56524 |
| Catalog # | MBS9701080 |
| Price | $130, $220, $325 |
| Order / More Info | HDAC4 (Phospho Ser632) Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.